Magic Shave Powder Gold's Affects on the Occurrence of Pseudofolliculitis Barbae

Pseudofolliculitis Barbae Clinical Trial

Official title:
Depilatory Cream's Affect on the Occurrence of Pseudofolliculitis Barbae

Status Withdrawn

Clinical Trial Summary

Comparing the amount of papules, macules, pustules, and irritation caused by pseudofolluculitis barbae in subjects using depilatory cream versus traditional shaving methods.

Clinical Trial Description

Comparing an experimental group that will remove facial hair with magic shave powder gold, and a control group that will continue using traditional shaving methods. Both the subject and a physician will make observations to determine the efficacy of depilatory creams in reducing pseudofolliculits barbae. ;

Study Design

Related Conditions & MeSH terms

Pseudofolliculitis Barbae

Clinical Trial Details

NCT number	NCT04220502
Study type	Interventional
Source	Wayne State University
Contact
Status	Withdrawn
Phase	Early Phase 1
Start date	August 1, 2020
Completion date	May 3, 2022

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT04403282` - Topical Eflornithine for Pseudofolliculitis Barbae: Randomized Controlled Trial	Phase 4
Active, not recruiting	`NCT03569956` - Shaving Satisfaction in Males With Skin Irritation From Shaving	N/A
Completed	`NCT04993066` - Clinical Evaluation to Assess the Safety and Efficacy of GentleMax Pro Plus	N/A
Completed	`NCT03043534` - Pre-Shave Gel and Brush in Pseudofolliculitis Barbae	N/A
Completed	`NCT00176995` - Effect of 15% Eflornithine Hydrochloride Cream on African-American Males With Pseudofolliculitis Barbae	Phase 2
Completed	`NCT00402129` - Low Fluence 1064nm Laser Hair Reduction for Pseudofolliculitis Barbae in Skin Types IV, V, VI	N/A